DBPAP/ Graphics Processing Unit (GPU) MD Workstation

The Food and Drug Administration, through its Center for Biologics Evaluation and Research, is forecasting the future procurement of a high-performance Graphics Processing Unit (GPU) MD Workstation to support advanced molecular dynamics simulations of bacterial polysaccharides and other biomolecules. This acquisition is targeted for use by the Laboratory of Bacterial Polysaccharides to enhance computational research capabilities, enabling more detailed and accurate modeling of complex molecular structures relevant to biologics development and regulatory science. The solicitation is classified under NAICS code 334118, indicating the purchase falls within the semiconductor and other electronic component manufacturing category, suggesting the workstation will include specialized hardware tailored for intensive scientific computing. The point of contact for program inquiries is the CBER Acquisition Liaison at cberacquisitions@fda.hhs.gov, while the contracting officer role is presently listed as to be determined, indicating the opportunity is in a preliminary forecasting stage and no formal request for proposals has been issued yet. The anticipated purchase is not subject to any set-aside provisions and is intended for performance at an unspecified location within the agency’s research infrastructure.